Literature DB >> 9651368

A hinge at the central helix of the regulatory light chain of myosin is critical for phosphorylation-dependent regulation of smooth muscle myosin motor activity.

M Ikebe1, T Kambara, W F Stafford, M Sata, E Katayama, R Ikebe.   

Abstract

The motor function of smooth muscle myosin is activated by phosphorylation of the regulatory light chain (RLC) at Ser19. However, the molecular mechanism by which the phosphorylation activates the motor function is not yet understood. In the present study, we focused our attention on the role of the central helix of RLC for regulation. The flexible region at the middle of the central helix (Gly95-Pro98) was substituted or deleted to various extents, and the effects of the deletion or substitution on the regulation of the motor activity of myosin were examined. Deletion of Gly95-Asp97, Gly95-Thr96, or Thr96-Asp97 decreased the actin-translocating activity of myosin a little, but the phosphorylation-dependent regulation of the motor activity was not disrupted. In contrast, the deletion of Gly95-Pro98 of RLC completely abolished the actin translocating activity of phosphorylated myosin. However, the unregulated myosin long subfragment 1 containing this RLC mutant showed motor activity the same as that containing the wild type RLC. Since long subfragment 1 motor activity is unregulated by phosphorylation, i.e. constitutively active, these results suggest that the deletion of these residues at the central helix of RLC disrupts the phosphorylation-mediated activation mechanism but not the motor function of myosin itself. On the other hand, the elimination of Pro98 or substitution of Gly95-Pro98 by Ala resulted in the activation of actin translocating activity of dephosphorylated myosin, whereas it did not affect the motor activity of phosphorylated myosin. Together, these results clearly indicate the importance of the hinge at the central helix of RLC on the phosphorylation-mediated regulation of smooth muscle myosin.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9651368     DOI: 10.1074/jbc.273.28.17702

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Site-directed spin labeling reveals a conformational switch in the phosphorylation domain of smooth muscle myosin.

Authors:  Wendy D Nelson; Sarah E Blakely; Yuri E Nesmelov; David D Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-07       Impact factor: 11.205

2.  Smooth muscle myosin phosphorylated at single head shows sustained mechanical activity.

Authors:  Hiroto Tanaka; Kazuaki Homma; Howard D White; Toshio Yanagida; Mitsuo Ikebe
Journal:  J Biol Chem       Date:  2008-04-11       Impact factor: 5.157

3.  Kinetic and motor functions mediated by distinct regions of the regulatory light chain of smooth muscle myosin.

Authors:  Shaowei Ni; Feng Hong; Paul D Brewer; Mitsuo Ikebe; Hirofumi Onishi; Jonathan E Baker; Kevin C Facemyer; Christine R Cremo
Journal:  Biochim Biophys Acta       Date:  2009-07-25

4.  Functional regulation of the SLC26-family protein prestin by calcium/calmodulin.

Authors:  Jacob Pearson Keller; Kazuaki Homma; Chongwen Duan; Jing Zheng; Mary Ann Cheatham; Peter Dallos
Journal:  J Neurosci       Date:  2014-01-22       Impact factor: 6.167

5.  The Regulatory and Kinase Domains but Not the Interdomain Linker Determine Human Double-stranded RNA-activated Kinase (PKR) Sensitivity to Inhibition by Viral Non-coding RNAs.

Authors:  S Sunita; Samantha L Schwartz; Graeme L Conn
Journal:  J Biol Chem       Date:  2015-10-02       Impact factor: 5.157

Review 6.  Fusion protein linkers: property, design and functionality.

Authors:  Xiaoying Chen; Jennica L Zaro; Wei-Chiang Shen
Journal:  Adv Drug Deliv Rev       Date:  2012-09-29       Impact factor: 15.470

7.  Agonist-induced changes in the phosphorylation of the myosin- binding subunit of myosin light chain phosphatase and CPI17, two regulatory factors of myosin light chain phosphatase, in smooth muscle.

Authors:  Naohisa Niiro; Yasuhiko Koga; Mitsuo Ikebe
Journal:  Biochem J       Date:  2003-01-01       Impact factor: 3.857

8.  Mechanical defects of muscle fibers with myosin light chain mutants that cause cardiomyopathy.

Authors:  Osha Roopnarine
Journal:  Biophys J       Date:  2003-04       Impact factor: 4.033

9.  Impacts of Usher syndrome type IB mutations on human myosin VIIa motor function.

Authors:  Shinya Watanabe; Nobuhisa Umeki; Reiko Ikebe; Mitsuo Ikebe
Journal:  Biochemistry       Date:  2008-08-13       Impact factor: 3.162

10.  Human myosin Vc is a low duty ratio nonprocessive motor.

Authors:  Shinya Watanabe; Tomonobu M Watanabe; Osamu Sato; Junya Awata; Kazuaki Homma; Nobuhisa Umeki; Hideo Higuchi; Reiko Ikebe; Mitsuo Ikebe
Journal:  J Biol Chem       Date:  2007-12-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.